Eli Lilly and Company

Medical Science Liaison - Immunology-Dermatology – Ontario West

Canada

Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Position Overview

  • Location Type: Remote
  • Employment Type: Full time
  • Company: Lilly

Brief Description: Lilly is seeking a Medical Science Liaison (MSL) specializing in Immunology and Dermatology to serve as a scientific resource for Canadian experts. The MSL will build and maintain relationships with the medical community, providing in-depth scientific information and gathering feedback to inform Lilly’s research and strategic direction. This role requires a strong understanding of immunology, dermatology, and autoimmune diseases, as well as adherence to all applicable guidelines and regulations.

Responsibilities

  • Serve as a scientific resource for Canadian experts in Dermatology and Immunology.
  • Respond to requests for in-depth, cutting-edge scientific information.
  • Provide updates on the latest scientific literature, research from conferences, and Lilly’s pipeline research activities.
  • Gather feedback and insight from Scientific Experts and Thought Leaders.
  • Facilitate scientific exchange between the academic community and Lilly.
  • Ensure all activities comply with applicable guidelines, regulations, and ethical standards (IMC Code of Conduct, Eli Lilly Canada Policy, etc.).

Requirements

  • (Details are missing in the provided text)

Company Information

Lilly is one of the top 10 largest pharmaceutical companies in the world. With a history of 135 years, Lilly is dedicated to creating medicines that improve people’s quality of life. The company’s core values include excellence, integrity, and respect for people. Lilly is committed to strong governance, ethical development of medicines, transparency, and ethical product promotion.

Skills

Immunology
Dermatology
Autoimmune Diseases
Scientific Communication
Research Literature
Conference Presentation
Regulatory Compliance
Ethical Standards

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI